Back to Search Start Over

Prevalence, risk factors, and recurrence risk of persistent air leak in patients with secondary spontaneous pneumothorax.

Authors :
Cheng HS
Lo YT
Miu FP
So LK
Yam LY
Source :
European clinical respiratory journal [Eur Clin Respir J] 2023 Feb 01; Vol. 10 (1), pp. 2168345. Date of Electronic Publication: 2023 Feb 01 (Print Publication: 2023).
Publication Year :
2023

Abstract

Background: Persistent air leak (PAL) is common in secondary spontaneous pneumothorax (SSP), with risk factors only been determined for post-pulmonary resection PAL. Information about its risk factors and long-term outcome is, however, necessary to enable selection of treatment modalities for elderly SSP patients with comorbid conditions.<br />Methods: A retrospective observational study was performed on chest drain-treated SSP patients from 2009 to 2018. The risk factors, long-term recurrent pneumothorax, and mortality rates of those with and without PAL were evaluated.<br />Results: Of 180 non-surgical SSP patients, PAL prevalence for >2 days and >7 days were 81.1% and 43.3%, respectively. Bulla was associated with PAL >7 days (OR: 2.32; P: 0.027) and serum albumin negatively associated (OR: 0.94; P: 0.028). PAL resulted in longer hospitalization in the index episode (P: <0.01). PAL >7 days was associated with a higher pneumothorax recurrence rate in three months (HR: 2.65; P: 0.041), one year (HR: 2.50; P: 0.040) and two-year post-discharge (HR: 2.40; P: 0.029). Patients treated with medical pleurodesis were significantly older (P: <0.01), had higher Charlson Co-morbidity index scores (P: <0.01), and 77.8% of those who had PAL >7 days were considered unfit for surgery. Of these, pneumothorax had not recurred in 69.4% after two years (HR: 0.47; P: 0.044).<br />Conclusion: Bulla was positively associated with PAL over seven days in SSP patients while albumin was negatively associated. PAL over seven days increased future recurrent pneumothorax risks, while elderly SSP patients unfit for surgery had acceptable recurrence rates after medical pleurodesis.<br />Competing Interests: No potential conflict of interest was reported by the authors.<br /> (© 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.)

Details

Language :
English
ISSN :
2001-8525
Volume :
10
Issue :
1
Database :
MEDLINE
Journal :
European clinical respiratory journal
Publication Type :
Academic Journal
Accession number :
36743827
Full Text :
https://doi.org/10.1080/20018525.2023.2168345